Insmed Incorporated DSO Ratio 2011-2026 | INSM

Annual DSO Ratio Insmed Incorporated

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
58	46.8	42.4	40.2	39.6	39.7	51.4	205	-	-	-	-	-	-	62.6

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
205	39.6	65

Quarterly DSO Ratio Insmed Incorporated

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
43.7	49	-	40.4	-	-	-	38.4	36.3	42.1	-	18.5	18	43	-	36.8	36.2	38.8	-	34.6	35.6	44.3	38.4	45.1	58.5	51.5	51.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	49.2	159	70.6	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
159	18	46.9

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
ACADIA Pharmaceuticals ACAD	37.5	$ 22.57	0.04 %	$ 3.74 B	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Akebia Therapeutics AKBA	62.9	$ 1.41	-1.4 %	$ 363 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Aravive ARAV	16.8	-	-13.39 %	$ 1.45 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Aytu BioScience AYTU	150	$ 2.56	-3.76 %	$ 16.1 M	USA
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.85	-1.39 %	$ 9.26 B	Australia
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Amphastar Pharmaceuticals AMPH	70.9	$ 20.87	2.3 %	$ 976 M	USA
Aquestive Therapeutics AQST	103	$ 4.17	-0.24 %	$ 446 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Arcutis Biotherapeutics ARQT	106	$ 24.57	-0.16 %	$ 3.13 B	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
CymaBay Therapeutics CBAY	182	-	-	$ 3.45 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	2.26 K	-	-	$ 1.41 B	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 2.93	-4.87 %	$ 6.38 B	Israel
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Celldex Therapeutics CLDX	321	$ 33.62	3.73 %	$ 2.23 B	USA
Concert Pharmaceuticals CNCE	147	-	-	$ 401 M	USA
Celsion Corporation CLSN	15.6	-	-6.63 %	$ 13.9 M	USA